+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 60Years
All Genders
ID06940258

Evaluating Ultrasound-Guided Caval Aorta Index for Fluid Management in Critically Ill Traumatic Brain Injury Patients

Led by Mansoura University · Updated on 2026-10-13

92

Participants Needed

1

Research Sites

34 weeks

Total Duration

AI-Summary

What This Trial Is About

Traumatic brain injury TBI is a major cause of death and disability in trauma patients. Since the initial brain injury cannot be reversed, treatment focuses on preventing further damage by avoiding low blood pressure and low oxygen levels, while maintaining proper brain blood flow. The study evaluates the use of the caval aorta index, a new ultrasound measurement, to guide fluid management in critically ill TBI patients. Participants will be randomly assigned to one of two groups a control group receiving a fixed fluid prescription, and an experimental group where fluid dosage is guided by ultrasound measurement of the caval aorta index. This index is a simple ratio of the inferior vena cava to aorta diameters, which can be measured effectively even by doctors with limited ultrasound experience. During the study, participants will be monitored closely with daily assessments including fluid balance after 96 hours of admission, urine output, central venous pressure measured every 6 hours for 7 days, blood pressure stability, Glasgow Coma Scale scores, capillary refill, and signs of pulmonary edema. These evaluations will help determine how fluid management impacts patient outcomes over the first week of critical care.

CONDITIONS

Brief Title

Caval Aorta Index for Fluid Optimization in Traumatic Brain Injury

Research Team

M

Maha Ahmed Abozeid, Professor

M

Mai Ibrahim Sobh, MBBS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here